Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

NCT01276613 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Per memo from study team

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: Losartan

Sponsor

M.D. Anderson Cancer Center